NM
PRVL

Newtyn Management’s Prevail Therapeutics Inc. Common Stock PRVL Stock Holding History

Newtyn Management’s Portfolio PRVL Stock Details PRVL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-153,617
Closed -$3.54M – 121
2020
Q4 		$3.54M Buy
+153,617
New +$3.54M 0.82% 36